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A Continuous-Flow Model for in vitro
Cultivation of Mixed Microbial
Populations Associated With Cystic
Fibrosis Airway Infections
Thomas James O’Brien and Martin Welch*
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
The airways of people with cystic fibrosis (CF) provide a nutrient-rich environment
which favours colonisation by a variety of bacteria and fungi. Although the dominant
pathogen associated with CF airway infections is Pseudomonas aeruginosa, it is
becoming increasingly clear that inter-species interactions between P. aeruginosa and
other colonists in the airways may have a large impact on microbial physiology and
virulence. However, there are currently no suitable experimental models that permit long-
term co-culture of P. aeruginosa with other CF-associated pathogens. Here, we redress
this problem by describing a “3R’s-compliant” continuous-flow in vitro culture model
which enables long-term co-culture of three representative CF-associated microbes:
P. aeruginosa, Staphylococcus aureus and Candida albicans. Although these species
rapidly out-compete one another when grown together or in pairs in batch culture,
we show that in a continuously-fed setup, they can be maintained in a very stable,
steady-state community. We use our system to show that even numerically (0.1%) minor
species can have a major impact on intercellular signalling by P. aeruginosa. Importantly,
we also show that co-culturing does not appear to influence species mutation rates,
further reinforcing the notion that the system favours stability rather than divergence.
The model is experimentally tractable and offers an inexpensive yet robust means of
investigating inter-species interactions between CF pathogens.
Keywords: cystic fibrosis, continuous-flow, co-culture, in vitro, Pseudomonas aeruginosa, Staphylococcus
aureus, Candida albicans
INTRODUCTION
Cystic fibrosis (CF) is the most common life-limiting genetic disorder within the Caucasian
population (Cystic Fibrosis Foundation, 2019), with 1 in 40 people estimated to carry
the common 1F508 mutation in the CF transmembrane conductance regulator (CFTR)
gene (Bobadilla et al., 2002; Cystic Fibrosis Mutation Database, 2019). The most striking
consequence of dysfunctional CFTR activity is the overproduction of nutrient-rich, mucilaginous
sputum. This blocks the airways and generates a heterogenous environment with steep
oxygen gradients and a lowered pH (Boucher, 2002; Tate et al., 2002; Worlitzsch et al.,
2002). This environmental niche is rich in nutrients such as mucin, amino acids, iron,
and nitrate making the CF airway prone to colonisation by a variety of microbial
species (Grasemann et al., 1998; Jones et al., 2000; Palmer et al., 2007; Ghio et al., 2013).
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The resulting infections often persist for decades, leading to
respiratory failure and eventually, premature death (Lyczak et al.,
2002; Rajan and Saiman, 2002; Carmody et al., 2013, 2015;
Elborn, 2016). Traditionally, these CF-associated infections have
been linked with a relatively small number of easily-culturable
pathogens, such as Pseudomonas aeruginosa or Staphylococcus
aureus. However, the introduction of culture-independent
molecular profiling approaches revealed that expectorated CF
sputum samples often contain a much wider range of bacterial
and fungal species (Sibley et al., 2006, 2008; Rogers et al., 2010a;
Zhao et al., 2012; Carmody et al., 2013, 2015; Short et al., 2014;
Boutin et al., 2015). This suggests that the CF airways may
harbour a highly-diverse microbial community, although this
notion has been challenged recently through the direct sampling
of lavage fluid from the lungs of CF children. These new data
suggest that to a large extent, the diversity of the previously
reported CF-associated microbiome arises from contamination
of the sample during passage through the oral cavity, and
following sample processing (Jorth et al., 2019). Nevertheless,
these newer studies still suggest that the CF airways harbour
a core population of “non-conventional” pathogens, including
Prevotella, Veillonella and Staphylococcus species, as well as
“traditional CF pathogens” such as P. aeruginosa (PA).
The polymicrobial character of many CF-associated airway
infections makes it crucial to consider what impact inter-species
interactions have on the physiology and composition of the
microbial consortium. Previous reports demonstrate that co-
culturing bacterial species in vitro and in vivo causes significant
alterations in gene essentiality (Ibberson et al., 2017). This
can lead to changes in microbial lifestyle, impacting upon the
expression of virulence factors (Rogers et al., 2009, 2010a,b;
Hibbing et al., 2010; Leekha et al., 2011; Elias and Banin,
2012; Quinn et al., 2014; Limoli et al., 2016). For example,
PA senses peptidoglycan shed from Gram-positive bacteria, and
this stimulates the production of extracellular lytic virulence
factors (Korgaonkar et al., 2013). Polymicrobial communities
also display altered responses to therapeutic intervention.
This may explain why many of the currently used clinical
interventions designed to target PA show varying degrees of
efficacy between patients (Lopes et al., 2012; Peters et al., 2012).
As a consequence of these conceptual realisations, research
focus is gradually moving away from studying individual species
in isolation toward co-cultivating the major CF associated
pathogens (Spasenovski et al., 2010; Bragonzi et al., 2012;
Filkins et al., 2015; Magalhães et al., 2016; Lopes et al., 2017;
Makovcova et al., 2017). However, these efforts are hampered
by the paucity of adequate polymicrobial infection models. The
development of a model which enables the stable and long-
term recapitulation of CF polymicrobial communities is therefore
highly-desirable.
Here we describe the development of a simple in vitro
continuous-flow co-culture model which utilises artificial sputum
medium (ASM). ASM is known to physiologically recapitulate
the nutritional composition of CF airway secretions (Palmer
et al., 2007; Kirchner et al., 2012; Turner et al., 2015). To
the best of our knowledge, our co-culture model (Figure 1)
is the first to permit the long-term, steady-state co-culture
of three distinct microbial species: PA, Staphylococcus aureus
(SA), and Candida albicans (CA). Through viable cell counting
and optical density measurements, we demonstrate that the
abundance of each member of this microbial population remains
unchanged over the course of 4 days and that a total carrying
capacity can be reached and maintained within the culture
vessel. By contrast, and in line with previous reports, when
these species are co-cultured under batch conditions, PA
rapidly outcompetes the other species (Machan et al., 1992;
Duan et al., 2003; Hogan et al., 2004; Mashburn et al., 2005;
McAlester et al., 2008; Cugini et al., 2010; Holcombe et al.,
2010; Morales et al., 2010; Park et al., 2012; Korgaonkar
et al., 2013; Baldan et al., 2014; Fugère et al., 2014; Rüger
et al., 2014; Barnabie and Whiteley, 2015; Filkins et al., 2015;
Nguyen et al., 2015; Zago et al., 2015; Nguyen and Oglesby-
Sherrouse, 2016). Our in vitro model provides a defined and
experimentally tractable system which can be used to dissect
interspecies interactions and determine the long-term impact of
co-cultivation on the physiology and gene expression profiles
of CF-associated pathogens. Our in vitro model also provides
a robust and cheaper alternative to existing in vivo infection
models, making it compliant with the current trend toward
the refinement, replacement and reduction (3Rs) of animal
models in research.
The species chosen for inoculation into our co-culture model
represent three distinct classes of microorganisms; a Gram-
negative species and dominant CF-associated pathogen (PA), a
Gram-positive species, often associated with CF airway infections
(SA) and a dimorphic fungus (CA), also commonly found in CF
airway secretions (Conrad et al., 2013). As such, our continuous-
flow model lays a solid groundwork for the development and
optimisation of an in vitro co-culture model which can be directly
inoculated with expectorated CF sputum. This will hopefully
enable, in the longer-term, full recapitulation of the CF-associated
polymicrobial community in defined laboratory conditions.
MATERIALS AND METHODS
Microbial Strains and Culture Conditions
The bacterial/fungal strains used in this study are shown
in Table 1. All bacterial strains were routinely cultured in
lysogeny broth (LB) (Formedium) with vigorous aeration at
37◦C overnight. Where necessary, cultures were supplemented
with 50 µg mL−1 carbenicillin (to maintain pSB1057 in the
N-(3-Oxododecanoyl)-L-homoserine lactone OdDHL biosensor
strain) or 10 µg mL−1 tetracycline (to maintain pSB536 in the
N-butanoyl-L-homoserine lactone BHL biosensor strain).
Artificial sputum medium was used for every mono-, dual-,
and triple-species cultivation. ASM was made using a modified
version of the recipe published by Turner et al. (2015). Briefly,
bovine maxillary mucin was replaced with 1.25 g L−1 porcine
stomach mucin type-II (Sigma-Aldrich) and salmon sperm
DNA was replaced with 1 g L−1 fish sperm DNA (Sigma-
Aldrich) as described by Kirchner et al. (2012). A detailed
protocol for preparing ASM can be found in the Supplementary
Information (SI.1).
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FIGURE 1 | Schematic diagram of the in vitro continuous-flow culture system used in this study. The main culture vessel (centre) is a 100 mL Duran bottle fitted with
a 4-port HPLC GL80 screwcap lid, containing 4 sealable inlet/outlet ports. A multichannel peristaltic pump delivers fresh media (ASM) into the culture vessel from a
reservoir, and also removes waste culture at the same rate of flow (Q). Arrows show the direction of flow. The culture vessel is incubated at 37◦C and the contents
are kept homogenous through gentle stirring. If required, an in-line spectrophotometer fitted with a continuous-flow cuvette can be included in the setup prior to the
discard jar. The value for Q depends on the microbial species being cultured within the vessel.
Continuous-Flow Culture Vessel and Culture
Conditions
A schematic of the continuous-flow culture system is shown in
Figure 1. The culture vessel consists of a 100 mL flask (Duran),
fitted with an assembled 4-port HPLC GL80 screw cap (Duran).
A 24-channel IPC ISM934C standard-speed digital peristaltic
pump (Ismatec) was used to deliver sterile ASM at a defined
flow rate (Q) through 1.5 mm bore sterilin silicon tubing (Fisher
Scientific) to the culture vessel. A different channel on the same
pump was used to remove waste culture into a discard jar at the
same flow-rate. The culture vessel was maintained at 37◦C and
its contents were kept homogenous by stirring (100 rpm) using a
magnetic stir bar. When necessary, the culture optical density was
monitored at 600 nm (OD600 nm) by passing the removed waste
culture through an in-line 6715 UV series spectrophotometer
(Jenway) fitted with a continuous-flow cuvette.
Overnight cultures were washed three times in sterile
1 × phosphate buffered saline (PBS, Oxoid) prior to inoculating
the culture vessel. Pre-warmed ASM (100 mL) in the culture
vessels was inoculated with the required combination of
microbial species. Each species was introduced into the culture
vessel to achieve a starting OD600 nm of 0.05. The vessel was
incubated for 3 h prior to staring the flow of medium. For mono-
species and co-culture experiments not containing CA, the flow
rate (Q) was set at 170 µL min−1. For co-culture experiments
including CA, Q was decreased to 145 µL min−1. For all
continuous-flow experiments, samples (1 mL volume) for cell
enumeration were withdrawn using a syringe fitted with a sterile
needle inserted through the rubber septa in the HPLC ports.
Aerobic and Stirred Batch Culture Conditions
For aerobic batch cultures, 250 mL Erlenmeyer flasks containing
pre-warmed ASM (inoculated with the indicated strains to a
starting OD600 nm of 0.05) were incubated at 37◦C with vigorous
shaking (180 rpm). Stirred batch cultures were set up as described
for the continuous-flow experiments (see section “Continuous-
Flow Culture Vessel and Culture Conditions”), except with
Q = 0 µL min−1. For both types of batch culture, samples (1 mL
volume) were taken from the culture vessel for OD600 nm analysis
and viable cell counting.
Microbial CFU mL−1 Enumeration
Colony forming units (CFU) per mL of culture were determined
using the single plate-serial dilution spotting (SP-SDS), as
described previously (Thomas et al., 2015). Serial dilutions
were made in sterile PBS and 20 µL of each dilution was
spotted onto the appropriate selective agar. PA was isolated using
pseudomonas agar base (Oxoid) supplemented with cetrimide
(200 µg mL−1) and sodium nalidixate (15 µg mL−1). SA was
isolated on mannitol salt agar (Oxoid). CA was isolated on
BiGGY agar (Oxoid). During co-culture experiments involving
CA, the agar plates used to isolate PA and SA were further
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TABLE 1 | Microbial strains used in this study.
Strain Description References
PAO1 Pseudomonas aeruginosa, spontaneous chloramphenicol-resistant derivative. Used worldwide as a
laboratory reference strain (isolated Melbourne, 1954).
Holloway, 1955
ATCC 25923 Staphylococcus aureus Rosenbach (ATCC R© 25923D-5TM), methicillin sensitive clinical isolate. Laboratory
reference strain lacking recombinases and mecA (isolated Seattle, 1945).
Treangen et al., 2014
SC5314 Candida albicans, clinical isolate commonly used as a wild-type laboratory reference strain (isolated
New York, 1980s).
Gillum et al., 1984
PAO1 1pqsA CTX-lux::pqsA PQS biosensor strain. 1pqsA mutant of PAO1 containing a pqsA promoter:: luxCDABE fusion integrated at
a neutral site in the chromosome.
Fletcher et al., 2007
JM109 (pSB1057) OdDHL biosensor strain. Escherichia coli JM109 containing pSB1057. Winson et al., 1998
JM109 (pSB536) BHL biosensor strain. Escherichia coli JM109 containing pSB536. Winson et al., 1998
supplemented with 5 µg mL−1 itraconazole to inhibit the growth
of CA. All plates were incubated at 37◦C. Pseudomonas agar
base and mannitol salt plates were incubated overnight (16 h).
BiGGY agar plates were incubated for 24 h. CFU mL−1 counts
are averages taken from three technical repeats. There was no
significant difference between total CFU mL−1 counts of pure
microbial cultures plated onto either non-selective (LB-agar) or
any of the selective agar (data not shown).
Quantification of Quorum Sensing
Molecules
Aliquots (1.5 mL) of culture were collected after 24 and 96 h (as
indicated) of incubation. The cells were pelleted by centrifugation
(15,000 × g, 5 min, 20◦C) and the supernatant was filtered
(0.22 µm pore size). Aliquots of the supernatant were snap
frozen in liquid N2 and stored at −20◦C until use. OdDHL
was detected using JM109 (pSB1057). BHL was detected using
JM109 (pSB536). PQS was detected using PAO1 1pqsA CTX-
lux::pqsA. Overnight starter cultures of the reporter strains were
sub-cultured in LB supplemented with the appropriate antibiotics
and grown to OD600nm = 1.0. Following this, aliquots (60 µL
volume) of the normalised cell culture were transferred to a
sterile clear-bottomed black opaque 96-well plate (Greiner Bio-
One) containing an equal volume of thawed culture supernatant.
The plates were incubated at 30◦C with shaking (100 rpm)
for 3 h. Bioluminescence was recorded using a FLOUstar
Omega plate reader (BMG). Standard curves to calibrate the
biosensor outputs were constructed using known concentrations
of synthetic quorum sensing molecules dissolved in ASM.
Quantification of Pyocyanin
Pyocyanin quantification was performed following chloroform
extraction of the pigment (Knight et al., 1979). Aliquots (10 mL
volume) of culture were collected after 96 h growth and the cells
were pelleted (4000 × g, 30 min, 4◦C). The culture supernatants
were filter sterilised (0.22 µm pore size). Chloroform (4.5 mL)
was added to 7.5 mL of the cell-free culture supernatant and
the suspension was vigorously vortexed for 30 s. The immiscible
layers were separated by centrifugation (4000 × g, 10 min,
4◦C). An aliquot (3 mL volume) of the blue-green chloroform
phase was removed and mixed with 1.5 mL 0.2M HCl. The
immiscible layers were then separated by centrifugation and
1 mL of the rose-pink phase was transferred to a cuvette.
The pyocyanin absorbance was measured at 520 nm using a
BioSpectrometer Kinetic spectrophotometer (Eppendorf) and
converted to concentration (µg mL−1) by multiplying the
A520 nm value by 26.6.
Estimation of Mutation Rates
Mutation rates in the chemostat were measured as described
by Foster (2006). Initially, the rate constant (λ) associated with
exponential growth of PA and SA co-cultured in ASM, was
determined by enumeration of CFU mL−1 on selective agar
plates. Next, the total cell count (N) within the culture vessel at
steady-state growth was determined. The number of spontaneous
rifampicin resistant PA or SA mutants, r, was measured after
t1 = 0 h, t2 = 24 h and t3 = 96 h of incubation. Total cell
numbers in the chemostat did not change appreciably between
24 and 96 h. The value of r was determined by plating aliquots
(100 µL volume) of culture onto either pseudomonas isolation
agar supplemented with 60 µg mL−1 rifampicin (for PA), or
mannitol salt agar supplemented with 0.05 µg mL−1 rifampicin
(for SA). The mutation rate per cell per generation (m) was
calculated according to Eq. 2 in Foster (2006);
µ = 1
Nλ
(r2 − r1)
(t2 − t1)
Statistical Analysis
Unless otherwise stated, all data represent the mean ± SD of
three independent biological experiments. Results were analysed
by one-way or two-way ANOVA (as indicated), or Student’s
unpaired t-test using GraphPad Prism version 8.2.0, with
P < 0.05 being considered statistically significant.
RESULTS
Mono-Species Continuous-Flow Culture
(PAO1)
As a first step, we confirmed that PA, SA and CA could all
grow in ASM. This was done by inoculating each species into
flat-bottomed microtitre plates containing ASM. The plates were
incubated at 37◦C with vigorous shaking (180 rpm) in a FluoStar
Omega plate reader, and the culture optical density (OD600)
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FIGURE 2 | Growth of P. aeruginosa in ASM in batch and continuous flow culture conditions. Growth (monitored as OD600) of PA in ASM during (A) continuous-flow
culture (Q = 170 µL min–1); (B) batch culture (Q = 0 µL min–1). Data represent the mean ± standard deviation from three independent experiments.
was monitored every 15 min. PA, SA and CA grew rapidly in
ASM, achieving a final OD600 of > 1 after 24 h in all cases
(Supplementary Figure S1).
Next, we measured whether a mono-species culture of PA
could be maintained with stable steady-state titres in our
continuous-flow setup. The laboratory reference strain, PAO1,
was inoculated into the continuous-flow system using a flow-rate
Q = 170 µL min−1 and the OD600 was measured every 30 min
as described in Section “Continuous-Flow Culture Vessel and
Culture Conditions.” The OD600 increased almost linearly for the
first 8 h and then reached a plateau (OD600 ≈ 0.4) after 10 h of
incubation (Figure 2A). By comparison, during growth in the
same medium and experimental setup with Q = 0 µL min−1
(i.e., in stirred batch mode), the PA culture reached a final OD600
of > 1 (Figure 2B). We conclude that during continuous-flow
operation, the setup allows the culture to achieve a steady-state
carrying capacity with an OD600 well-below the final OD600
associated with entry into the stationary phase of growth in
the same medium.
Dual-Species Co-culture (PA-SA)
Staphylococcus aureus is also associated with CF airway infection
and is particularly prevalent in adolescent patients (Goss and
Muhlebach, 2011; Conrad et al., 2013; Jorth et al., 2019). Despite
PA and SA being frequently co-isolated from CF patients,
numerous antagonistic interactions have been identified between
these species, and PA readily outcompetes SA in vitro in mixed
cultures (Machan et al., 1992; Duan et al., 2003; Mashburn et al.,
2005; Park et al., 2012; Korgaonkar et al., 2013; Baldan et al.,
2014; Fugère et al., 2014; Rüger et al., 2014; Filkins et al., 2015;
Nguyen et al., 2015). We therefore wanted to determine if the
two species could be stably maintained in our continuous-flow
culture system. We found that a mixed species co-culture of
PA and SA could be readily maintained to yield an apparently
stable steady-state composition using Q = 170 µL min−1. The
CFU counts for each species are shown in Figure 3A, and the
co-culture OD600 measurements are shown in Supplementary
Figure S2. A steady state composition of around 107 SA CFU
mL−1 and 108 PA CFU mL−1 was established by 24 h of growth,
and there were no significant differences in the viable cell counts
following this (P > 0.05) up to 96 h of growth. By contrast,
during aerobic batch culture in flasks, PA rapidly outcompeted
SA and no viable SA could be recovered at the 96 h sampling
point (Figure 3B). PA also outcompeted SA during stirred batch
co-culture conditions (Q = 0 µL min−1) in the continuous-flow
vessel (Figure 3C), albeit at a slower rate. Taken together, these
data indicate that a continual supply of fresh media and removal
of waste products is crucial for permitting a successful PA-SA
co-culture in vitro.
Dual-Species Co-culture (PA-CA)
Fungi, such as Candida sp. and Aspergillus sp. are also associated
with CF airway infections (Williams et al., 2016; Bouchara et al.,
2018). We therefore examined whether Candida albicans (CA)
could be maintained alongside PA in the continuous-flow setup.
This is important because inter-kingdom interactions between
PA and CA have been previously shown to affect virulence factor
production by both species (Hogan et al., 2004; McAlester et al.,
2008; Cugini et al., 2010; Holcombe et al., 2010). We found that
a co-culture of PA and CA could be readily maintained in the
continuous-flow setup (Figure 4A), although to prevent a wash-
out of CA from the culture vessel over time we had to decrease
the flow rate (Q = 145 µl min−1). The culture carrying capacity
for CA (ca. 105 CFU mL−1) was lower than it was for PA (ca.
108 CFU mL−1), but once a steady-state had been achieved
(after 24 h incubation) no statistically significant differences
in PA or CA viable cell counts were observed (P > 0.05). In
contrast, CA titres rapidly declined during aerobic batch co-
culture (Figure 4B). A similar, albeit slower decline in CA titres
was observed during stirred batch growth (Figure 4C).
Dual-Species Co-culture (SA-CA)
We next wanted to confirm that a stable co-culture of SA
and CA could be maintained independent of PA. Using
Q = 145 µL min−1, this was indeed the case (Figure 5A),
and after 24 h growth, the ratio of SA:CA remained essentially
unchanged. As in the PA-CA co-culture, at steady-state, the
carrying capacity (ca. 105 CFU mL−1) for CA was lower than
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FIGURE 3 | Continuous-flow culture allows P. aeruginosa and S. aureus to be maintained in a stable steady-state. Viable cell counts [colony forming units (CFUs)] of
P. aeruginosa PAO1 (PA, black bars) and S. aureus 25923 (SA, white bars) during co-culture in ASM using: (A) a continuous-flow setup; (B) aerobic batch culture;
and (C) stirred batch culture. Data represent as mean ± standard deviation from three independent experiments. Asterisks represent significant (∗P < 0.05)
differences in CFU mL–1 counts in comparison with the data from the 24 h time point.
it was for SA (ca. 108 CFU mL−1). Unexpectedly, we noted that
following aerobic and stirred batch culture, the CA outcompeted
the SA (Figures 5B,C). This confirms that in mixed cultures, a
species comprising just 0.1% of the microbiota can potentially
have a major impact on titres of the [initially] numerically-
dominant organism.
Triple-Species Co-culture
With the continuous-flow culture system clearly capable of
maintaining dual-species co-cultures of PA-SA, PA-CA and CA-
SA, we next wanted to determine if all three species could be
co-cultured to achieve a stable steady-state composition. We
found that setting Q = 145 µL min−1, a mixed population of all
three microbial species could be maintained at a steady state for
96 h of incubation (Figure 6A; the corresponding in-line OD600
data are shown in Supplementary Figure S3). Once the steady-
state had been achieved (i.e., after 24 h of growth) there were no
significant differences in the CFU mL−1 counts for each species
for the remaining duration of the co-culture (P > 0.1). The
PA and SA titres remained at around 108–109 CFU mL−1, and
the CA titres remained at around 105 CFU mL−1. By contrast,
when co-cultured in aerobic batch culture, both SA and CA were
outcompeted by PA (Figure 6B). Indeed, there was a progressive
decrease in the number of SA CFUs in each of the samples
harvested after the 24 h time-point (P < 0.0005), and by 72 h,
no viable CA CFU could be recovered. However, and unlike
the PA-SA aerobic dual cultures (Figure 3B), SA could still be
recovered at the 96 h sampling point, suggesting that the presence
of CA affords a degree of protection, perhaps by decreasing the
direct competition between PA and SA for shared resources. The
stirred batch co-cultures yielded a somewhat different pattern
(Figure 6C). Here, following the 24 h sampling point, PA titres
remained high (ca. 109–1010 CFU mL−1) and constant, but there
was a significant and progressive decrease in SA titres (P < 0.05).
Unlike the aerobic batch culture, this was accompanied by a much
slower decline in CA titres.
Quantification of P. aeruginosa Quorum
Sensing Molecules
Quorum sensing (QS) mediated signalling pathways are linked
to the regulation of secondary metabolite and extracellular
virulence factor production by PA. Some of these QS-regulated
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FIGURE 4 | Continuous-flow culture allows P. aeruginosa and C. albicans to be maintained in a stable steady-state. Viable cell counts (CFU) of P. aeruginosa PAO1
(PA, black bars) and C. albicans SC5314 (CA, grey bars) during co-culture in ASM using: (A) a continuous-flow setup; (B) aerobic batch culture; and (C) stirred
batch culture. Data represent as mean ± standard deviation from three independent experiments. Asterisks represent significant differences in CFU mL–1 counts in
comparison with the data from the 24 h time point (∗∗P < 0.005, ∗∗∗∗P < 0.0001).
factors have been implicated in mediating interactions with
other microbial species (Gambello et al., 1993; Smith and
Iglewski, 2003; Lau et al., 2004; Schuster and Greenberg, 2006;
Dekimpe and Déziel, 2009; Antunes et al., 2010). To examine
how other microbial species might impinge on QS in PA, we
therefore determined the concentration of the Pseudomonas
quinolone signal (PQS), N-(3-Oxododecanoyl)-L-homoserine
lactone (OdDHL) and N-butanoyl-L-homoserine lactone (BHL)
in the culture supernatant of single and mixed species co-cultures
(Figures 7A–C, respectively).
The concentration of all three QS molecules was significantly
(P < 0.0001) lower in the continuous-flow setup compared with
the aerobic- and stirred-batch cultures. In the continuous-flow
setup, there was no significant difference in the concentration of
PQS between the 24 and 96 h sampling points, or of OdDHL
between these sampling points (P > 0.1), although we did note
an increase in BHL concentration in the PA-CA co-culture over
this period (P > 0.05). In contrast, QS molecules accrued to
much higher concentrations in the aerobic- and stirred-batch
cultures. Moreover, the presence of co-cultivated species had a
large, but differential impact on QS molecule production by PA.
For example, in batch culture, SA appeared to stimulate OdDHL
production, whereas CA appeared to depress OdDHL levels and
stimulate PQS (and to a lesser extent, also BHL) production.
Taken together, our data indicate that QS molecules accumulate
to a much lower concentration in the continuous-flow setup
compared with batch cultures.
Quantification of Pyocyanin
Pyocyanin is a redox-active PA secondary metabolite, and is
linked with virulence and competition between microbial species
in the CF lung (Castric, 1975; Hoffman et al., 2006; Voggu
et al., 2006; Biswas et al., 2009; Filkins et al., 2015; Noto et al.,
2017). We measured pyocyanin levels in the different culture
setups at the endpoint of each experiment (Figure 8). Pyocyanin
concentrations were significantly lower for all microbial species
combinations in the continuous-flow setup compared with the
aerobic- or stirred-batch cultures (P < 0.0001). No significant
differences were observed in pyocyanin accumulation between
the different microbial co-culture combinations following growth
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FIGURE 5 | Continuous-flow culture allows S. aureus and C. albicans to be maintained in a stable steady-state. Viable cell counts of S. aureus 25923 (SA, white
bars) and C. albicans SC5314 (CA, grey bars) co-cultures in ASM in: (A) a continuous-flow setup; (B) aerobic batch culture; and (C) stirred batch culture. Data
represented as mean ± standard deviation of three independent experiments. CFU mL–1 values are plotted on a log10 scale and asterisks represent significant
differences in CFU mL–1 counts in comparison with the data from the 24 h time point (∗∗P < 0.005, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
in the continuous-flow setup (P > 0.3). However, we did
note that in the batch cultures, the presence of CA depressed
pyocyanin accumulation.
Estimation of Mutation Rates in
Co-cultures of P. aeruginosa and
S. aureus
One possible use of the continuous-flow system described here
would be to investigate how the presence of co-habiting species
affects evolutionary trajectory(s). To gauge this, we measured the
mutation rate of each species during co-culture. Mutation rates
were measured as described by Foster (2006) and were assessed
shortly after the steady-state had been attained (i.e., at the 24 h
time-point) and at the end of the experiment (96 h time-point).
The mean number of RifR-conferring mutations per cell division
was comparable with previously-reported values [≈10−8–10−9
mutations/cell/division (Schaaff et al., 2002; Dettman et al.,
2016)] and was consistently low for both PA and SA, with
no statistically significant differences between the 24 and 96 h
sampling points (P > 0.1) (Figure 9). We conclude that PA and
SA do not exhibit abnormal mutability in the continuous-flow
setup and that co-culture of these species has no apparent impact
on their respective mutation rate.
Continuous-Flow Cultures Maintain a
Constant pH
We also examined the endpoint pH of mixed-species cultures
to see whether this differed from the starting pH of ASM
(pH 6.7). We found that irrespective of the microbes and
combinations of microbes being tested, the continuous flow
cultures maintained a remarkably constant pH that was close to
the starting pH. Stirred batch cultures maintained a pH of ca.
7, whereas aerobic batch cultures exhibited an endpoint pH > 8
(Supplementary Figure S4).
DISCUSSION
In this work, we have shown that a simple in vitro continuous-
flow co-culture system enables long-term co-culture of three
distinct microbial species (PA, SA and CA) associated with CF
airway infections. When co-cultured in batch, these organisms
ordinarily outcompete one another, leading to domination by
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FIGURE 6 | Continuous-flow culture allows P. aeruginosa, C. albicans, and S. aureus to be maintained in a stable steady-state. Viable cell counts of P. aeruginosa
PAO1 (PA, black bars) S. aureus 25923 (SA, white bars) and C. albicans SC5314 (CA, grey bars) co-cultures in ASM in: (A) a continuous-flow setup; (B) aerobic
batch culture; and (C) stirred batch culture. Data represented as mean ± standard deviation of three independent experiments. CFU mL–1 values are plotted on a
log10 scale and asterisks represent significant differences in CFU mL–1 counts in comparison with the data from the 24 h time point (∗∗P < 0.05, ∗∗∗P < 0.001).
a single species. However, in the setup described here, once a
steady-state has been achieved (after around 24 h incubation)
each inoculated species can be maintained at a constant titre,
presumably reflecting the carrying capacity for each organism
in the culture. Significantly, we show that even low-abundance
species (represented by CA in our model) can be stably
maintained, and that the presence of such species can have
a major impact on the population trajectory of numerically
more-abundant organisms such as SA, as well as inter-cellular
signalling by PA.
The airways of people with CF have been shown to harbour a
diverse polymicrobial community, comprising both bacteria and
fungi (Sibley et al., 2006, 2008; Rogers et al., 2010a; Zhao et al.,
2012; Carmody et al., 2013, 2015; Short et al., 2014; Boutin et al.,
2015), and through the efforts of several teams, we now have a
well-defined ASM for in vitro analyses. Indeed, PA grown in ASM
has an almost identical gene expression profile compared with
PA grown directly in sputum derived from CF patients (Turner
et al., 2015). In spite of this, to date, there have been no reports
describing the successful, long-term co-culture of CF-associated
microbes in ASM. As we demonstrate in the current work,
simply adding mixed-species inocula into ASM is not a recipe
for the long-term maintenance of a stable population. Perhaps
the best measure of the lack of progress on this front is seen
when considering PA and SA. These two species are common
in CF infections, and decades of work have revealed a wealth of
knowledge about their physiology and nutritional requirements
in axenic culture. However, until now, there have been no studies
describing the successful long-term co-cultivation of these two
species in vitro. One possible reason for this is that in iron limited
conditions, PA lyses SA and uses the resulting lysate as a source
of iron (Mashburn et al., 2005). By providing a continual supply
of fresh media (which presumably mimics the unrelenting and
exuberant production of airway secretions in the CF lung) we
speculate that this nutritional limitation may be overcome.
The in vitro system described here offers a number of
advantages. First, it is inexpensive to set up, making it accessible
as a model to most researchers. Second, it is compliant with
the “3Rs” (the replacement, refinement and reduction of animal
research). Third, it is robust, as attested by the remarkably
constant titres of each species following attainment of the steady-
state condition. Fourth, early indications are that it can faithfully
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FIGURE 7 | Quorum sensing molecule accumulation in the different culture setups. Concentration of the indicated P. aeruginosa quorum sensing molecules in the
supernatant of single-species or multi-species co-cultures after 24 and 96 h incubation (as indicated). (A) Pseudomonas quinolone signal (PQS);
(B) N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL); (C) N-butanoyl-L-homoserine lactone (BHL). Data represented as mean ± standard deviation of three
independent experiments.
maintain species diversity when patient-derived CF sputum is
being used to inoculate the system, and our progress on that
aspect of the model will be published presently. Fifth, the system
is far more defined and controlled than an animal model,
allowing facile experimental perturbation. This experimental
tractability means that we can address biological questions
in a way that is just not possible with, e.g., animal models.
For example, new species or defined mutants can be readily
introduced to examine their impact on succession dynamics, and
the action of antibiotics on the entire community can be accessed.
We have also been exploring ways of modifying the setup to
promote biofilm growth in the culture vessel, and again, these
findings will be published in the near future.
Our in vitro setup is also subject to a number of perceived
disadvantages. Unlike an animal model, it does not incorporate
any immune response. This may be significant since the
immune response would be expected to play a major role in
clearance of microbes from the airways, and therefore exerts
a selective pressure on the microbial community. Also, our
model does not incorporate other types of host cell. This may
be significant because in some circumstances (e.g., in patients
carrying the DF508 CFTR mutation) the altered cell surface
on the epithelia lining the airways has been implicated in
promoting microbial colonisation (Campodónico et al., 2008).
Mitigating these features, we note that few animal models
accurately recapitulate the human CF airway environment,
and aside from the difficulties associated with controlling and
sampling such models, as far as we are aware, none of these
models have yet been developed for maintaining a polymicrobial
community of CF pathogens (O’Brien and Welch, 2019). One
other potential disadvantage of our model is the requirement
for continual flow. On the one hand, this is a feature that
does allow maintenance of a stable steady-state community of
microbes. On the other hand, even at low Q values, “washout”
may prevent slow-growing species/variants from thriving, or key
molecules from accumulating. For example, we noted that QS
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FIGURE 8 | Pyocyanin accumulation in the different culture setups. The
concentration (µg mL–1) of pyocyanin in the supernatants of single-species
and co-cultures after 96 h of incubation under: continuous-flow (black bars);
aerobic batch (grey bars) and; stirred batch (white bars) culture conditions.
Data represented as mean ± standard deviation of three independent
experiments, P > 0.05 is considered no significant difference (ns).
FIGURE 9 | Mutation rates of P. aeruginosa and S. aureus during co-culture in
the continuous-flow setup. Assumed mutation rates of P. aeruginosa PAO1
(black bars) and S. aureus 25923 (white bars) in the continuous-flow culture
vessel after 24 and 96 h of incubation. Mutation rates were calculated as the
number of RifR-conferring mutations per cell per cell division, calculated as
described by Foster (2006). The bars represent the mean ± standard
deviation from three independent experiments. P > 0.05 is considered not
significantly different (ns).
molecules (and pyocyanin) fail to accumulate in the continuous-
flow system, whereas these compounds reached high levels in
batch culture. The most likely explanation for this is simple
washout (through continual dilution) of the QS signals. However,
it should be noted that with Q = 170 µL min−1, it would
take > 6 h to dilute the vessel contents by 50%, and all the
while, the contained culture continues to grow and elaborate
more QS molecules. To put this into context, previous work has
shown that QS molecules more than double their concentration
in batch cultures in a 2 h period (Davenport et al., 2015),
so assuming similar kinetics in ASM, these molecules should
accumulate faster than they are diluted. If so, this suggests that
QS plays a less important role in continuous-flow cultures than
it does in batch cultures. The low steady-state concentrations
of QS molecules documented here may also be advantageous
(for the experimenter). First of all, the metabolic physiology of
the community is defined and stable over the experiment’s time
course and we would not expect to see the bursts of metabolic
activity which would normally accompany the accumulation of
QS molecules in the post-quorate period (Davenport et al., 2015).
Second, and if the effect(s) of QS molecules on community
interactions does need to be examined, this can be easily
be done through the addition of defined concentrations of
exogenous QS molecules.
We conclude that the setup described here enables facile
maintenance of PA, SA and CA (a Gram-negative bacterial
species, a Gram-positive bacterial species and dimorphic fungus,
respectively). Our approach provides a framework for potentially
recapitulating the entire polymicrobial community associated
with CF airway infections. The setup will provide leverage
to access to key biological problems regarding inter-species
interactions, the impact of antibiotics, and the impact that newly-
introduced species may have on the community trajectory.
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